Just released - Listed@ASX Winter 2023 edition
June 2023
Listed@ASX
Your go-to source for Australian IPO and Listing news, insights and analysis.
June 2023
Welcome to the latest edition of Listed@ASX Magazine.
The ASX listings team is delighted to bring you a bumper edition of Listed@ASX featuring interviews with listed company leaders, case studies and features on trending topics.
Plus, we are pleased to announce the launch of ASX’s Investor Study – the authoritative guide on investor trends and behaviour since 1986.
Last month we celebrated the 120th listing anniversary of Washington H Soul Pattison and Co (ASX: SOL) here at ASX’s Exchange Square. In our lead story, we speak to managing director, Todd Barlow about the company’s journey from its roots as a pharmacy provider to a vibrant, diversified investment business.
ASX’s new Investor Survey gives listed businesses up-to-date insights into different investor groups’ priorities and preferences so they can meaningfully engage with them. Find out more and download the full report.
For more information contact the ASX Listings team.
Giri Tenneti speaks to Australian Clinical Labs CEO, Melinda McGrath.
Giri Tenneti speaks to Richard White, Founder and CEO of Wisetech Global
James Posnett speaks to Dr. Alan Taylor, Executive Chairman of Clarity Pharmaceuticals
For more information contact the ASX Listings team.
The views, opinions or recommendations of the author in this article are solely those of the author and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way due to or in connection with the publication of this article, including by way of negligence.